Last edition
News about Market
Sanofi to acquire clinical-stage mRNA therapeutics company, Translate Bio for US$ 3.2 billion
As part of Sanofi's endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company
Market | 04/08/2021 | By Darshana | 182
Oximeters, BP machines and 3 other devices to get cheaper as trade margins capped at 70%
The National Pharmaceutical Pricing Authority has capped trade margins at 70 percent for pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer. The revised prices come into effect from July 20.
Market | 14/07/2021 | By Darshana | 185
Redcliffe Lifetech introduces mucormycosis multiplex RT-PCR test to detect DNA of Mucorales species
Redcliffe Lifetech, a leading molecular diagnostics company, has introduced a non-invasive (serum/fluid) RT-PCR test to detect the DNA of Mucorales species. As a part of the diagnostic process, BAL samples will be used to directly detect the infection, with sample-to-result collection in less than 24 hours
Market | 03/06/2021 | By Darshana | 271
UK MHRA approves one-dose Janssen Covid-19 vaccine
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted regulatory approval for the Janssen's Covid-19 vaccine. This is the fourth Covid-19 vaccine to be authorised by the UK's independent regulator and is the first to be approved for protection against Covid-19 with a single dose
Market | 31/05/2021 | By Darshana | 260
Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro sum in its production facility in Memphis, USA
Market | 25/09/2020 | By Hemant | 391
FDA Proposes New Rule on Reporting RequirementUnder Right to Try Act
Today, the U.S. Food and Drug Administration published the proposed rule, Annual Summary Reporting Requirements Under the Right to Try Act, that when finalized, will implement a statutory requirement for sponsors and manufacturers to provide annual summary to the FDA for any eligible investigational drug they provide to eligible patients under Try Act
Market | 27/07/2020 | By Darshana | 548
FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology
Market | 11/06/2020 | By Darshana | 757
Dr. Reddy's Labs completes acquisition of select business divisions of Wockhardt
Dr. Reddy's Laboratories Ltd announced that it has completed the acquisition of select divisions of Wockhardt Limited's branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives
Market | 10/06/2020 | By Darshana | 648
The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online
Market | 09/06/2020 | By Darshana | 448
Merck and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical development for the treatment of patients with COVID-19
Market | 28/05/2020 | By Darshana | 366
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy